Stockreport

Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19

Immunome, Inc.  (IMNM) 
PDF First study subject has been dosed in a single dose/dose escalation study of recently diagnosed COVID-19 patientsStudy will evaluate safety as the primary end point with [Read more]